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INTRODUCTION
Why do sickle cell disorders (SCDs) remain 
a low priority on the global child health 
agenda when a child dies from the condition 
every three seconds globally? Why are more 
resources not invested to save lives and ensure 
holistic care of people with SCDs? Why is 
policy focus shifting towards development 
of genomic cures instead of assuring better 
healthcare for people across the life- course? 
The disconnect between policy and practice 
raises further questions. What is the point of a 
cure if you live in poverty, do not have basics 
of healthcare and are susceptible to dying 
from a myriad of other diseases or during 
a pandemic? For many people, the major 
complications of inherited genetic conditions 
like SCDs include intractable pain, organ 
failure and death, that are often triggered by 
environmental factors such as malnutrition, 
dehydration, changes in temperature and 
stress, all of which are closely tied to socioec-
onomic factors.
RESEARCH AND PRACTICE IN SILOS
The preceding global and local inequities 
have been frustrating, working in our narrow 
disciplines of health systems, mental health, 
housing, gender and employment linked to 
SCD interventions as people with SCDs them-
selves are advocating for a holistic social justice 
perspective to SCDs. Similar to public health 
models that view disease through a medical 
lens, working in our silos has promoted a 
compartmentalisation of upstream inequal-
ities and sociopolitical decisions that affect 
people’s health. Moreover, as the COVID-19 
pandemic in high- income countries illus-
trates,1 2 although healthcare access is a crit-
ical human right, societal inequality affects 
which populations become more affected. A 
more holistic public health policy approach 
which is grounded in social justice is now 
urgently demanded. We therefore argue that 
adopting a ‘social determinants of health’ 
(SDH) approach will invigorate public health 
responses to addressing local and global 
health inequalities. We start by defining SDH 
before providing some background to why 
SCDs are neglected on the global health 
agenda. Then, we turn to practical policy 
implications of such an approach and the 
design of needed interventions for health.
SOCIAL DETERMINANTS OF HEALTH
SDH refer to the conditions, in the context 
and places, in which individuals are born, 
grow, live (including play, learn and work) 
and age3 4 and SDH are in turn affected by 
social, political and economic structures, that 
Summary box
 ► Sickle cell disorders are a complex multisystem in-
herited genetic blood disorders that affect millions 
of people worldwide and complications of the disor-
ders can include anaemia, pain episodes and organ 
damage.
 ► Medical advances, early detection, intervention in 
infancy and specialised care across the life- course 
are transforming these genetic blood disorders into 
chronic conditions, with longer life expectancies and 
better quality of life, yet public health debates con-
tinue to view sickle cell disorders as purely biomed-
ical problems that need to be prevented.
 ► We argue that adopting a social determinants of 
health approach to sickle cell disorders can help to 
move the policy focus from viewing sickle cell dis-
orders as burdens to be prevented, to a more holis-
tic perspective that would ensure better health and 
well- being across the life- course.
 ► The social determinants of health promotes a social-
ly just and ethical framing of health and well- being 
in all policies, that are fundamental to achieving 
the United Nations Sustainable Development Goals 
(SDGs), including SDG 10—of reducing health in-
equalities within and between countries.
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for example, affect healthcare systems. Context here, 
includes cultural and societal values placed on health, 
and the extent to which health is regarded as a social 
concern as well as a human right. By addressing these 
conditions and structures, we can progress someway to 
combating inequalities and ensuring equity for people 
with SCDs.5 Analysing the conditions in which people 
live across the life- course (from birth through to old age 
rather than cross- sectionally) offers a holistic interpreta-
tion of health and well- being at all ages. The SDH also 
intersects with more than just the third United Nations 
(UN) Sustainable Development Goal (SDG 3) on health 
and well- being in society but incorporates all 17 goals. 
Likewise, SDH are connected to the WHO’s One Health 
agenda to ensure universal healthcare for all people, as 
well as debates about universal basic income, assuring 
citizens of a country, a basic income or living stipend. 
The above issues are important to understanding SCDs.
SCDS AND THE GLOBAL CHILD HEALTH AGENDA
SCDs are complex multisystem inherited genetic blood 
disorders that affect millions of people worldwide. SCD 
includes the most common subtype in sub- Saharan 
Africa, caused by the homozygous mutation in the beta- 
globin gene (HBB) that results in the production of an 
abnormal form of beta- globin called beta- S- globin (Hb 
SS, often called sickle cell disease);6 a separate mutation 
in HBB that results in production of another abnormal 
form of beta globin called beta- C- globin (Hb SC) viewed 
as milder form of SCD and a rare subtype in sub- Saharan 
Africa HbS/beta0thalassaemia.7 Despite being declared 
a major global public health priority by the UN General 
Assembly,7 SCD is yet to attain prominence on the global 
child health agenda. Approximately, 300 000 babies with 
sickle cell disease are born globally each year8 and 70% 
of these births occur in sub- Saharan Africa. Addition-
ally, there are around 150 000 child deaths per year due 
to sickle cell disease, a figure higher than child deaths 
from HIV/AIDS related causes.9 The WHO estimates 
that around 2% of births in sub- Saharan Africa are now 
of SCDs and that mortality particularly affects infants, 
adolescents and pregnant women with the condition.10 
In West African countries, like Nigeria, due to improve-
ments in child and maternal mortality rates, as well as 
an estimated one in four people being carriers of the 
sickle mutation,11 the population of people with SCD 
is expected to grow. Similarly, more children with SCD 
are expected to be born globally in Latin- America, Asia, 
Europe and the Middle East but public health policy has 
been slow to prepare for the increase in SCD.12
CHRONIC CONDITIONS?
Fortunately, medical advances, early detection and inter-
ventions in infancy, as well as specialised multidisciplinary 
management across the life- course in high income coun-
tries, is progressively transforming SCDs into chronic 
conditions with longer life expectancy and higher quality 
of life.13 14 Despite this transformation, contemporary 
public health discourses still view SCDs as biomedical 
‘burdens’ to be prevented. Correlated to these discourses, 
we argue that health policies espoused by states typically 
revolve around four themes:15 (1) understanding prev-
alence; (2) saving lives through screening services; (3) 
ensuring informed decision- making through access 
to education and reproductive options and (4) timely 
healthcare and treatment from healthcare providers. 
Notwithstanding the potential of such policies to catalyse 
improved health outcomes for communicable and non- 
communicable conditions, these policies have typically 
been neglected in many African countries, thus forcing 
individuals to assume the responsibility for some of the 
strategies with untold psychosocial impacts on them.
The prevailing context of political neglect of policies, 
limited health systems infrastructure and the narrow 
biomedical interpretation of SCDs as burdens to be 
prevented have stimulated global investments in genomic 
cures for SCD in Africa, for example by the Bill and 
Melinda Gates Foundation.16 While assurances have been 
made that people in low- income countries will access 
novel genomic cures, nonetheless, medical cures, on 
their own, do not address everyday concerns of persons 
with SCD, especially in the context of ongoing corona-
virus pandemic, that include access to psychosocial care, 
basic medicines to manage severe pain, housing, educa-
tion, employment and ensuring their and their families’ 
general health and well- being. Furthermore, whereas the 
availability of the disease modifying drug, Hydroxyurea, 
is welcome news, unfortunately, the annual cost of taking 
Hydroxyurea for SCD (US$300) makes it very expensive 
for most people in sub- Saharan Africa. Even access to 
routine treatments like blood transfusions or pain medi-
cations are financially prohibitive for patients in many 
African countries where payment is expected for care. 
How can we change this?
THE IMPERATIVE OF THE SOCIAL DETERMINANTS OF SCDS
To ensure a socially just and ethical framing of SCDs, 
adopting an SDH17 perspective is imperative to under-
standing the intersection of SCD with conditions of 
poverty, infectious diseases and environmental triggers 
that act as risk factors. The SDH views health and well- 
being in all policies, as central to achieving the 2030 
UN SDGs. In the figure below, we have outlined how 
adopting an SDH lens would mean viewing health condi-
tions not as SDH lens would mean viewing health condi-
tions not as ‘burdens that need control’ but in terms of 
social justice in total policy environment for sustainable 
and long- term health for all.18 This is especially impor-
tant in low- income countries where interventions for 
people with SCDs should be combined with broader 
investments in the health of the general population. The 
figure builds on George Engel’s biopsychosocial model 
which argued that understanding the determinants of a 
person’s disease condition required a consideration of 
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the biological causes of disease and the psychological 
and social factors.19 To extend Engel’s work, Dahlgren 
and Whitehead20 argued that policies and strategies for 
tackling social inequities in health should focus on key 
determinants of health that lie outside the health system, 
including a range of economic growth strategies, inequi-
ties in incomes, poverty, unemployment and education.
Adapted from Dahlgren and Whitehead’s rainbow 
model of the SDH, our figure 1 (hereafter called the 
SICKLE model) depicts a range of factors that can help 
to move the focus from purely biomedical care of SCD 
to adopting person- centred approach and help increase 
the understanding of separate but interlinked factors 
between the biomedical approach and the wider deter-
minants of health. The figure uses concentric circles 
(representing individual, community, organisational 
and wider social contexts) to account for epigenetic, 
psychosocial and environmental factors that influence 
SCDs outcomes. These include individual lifestyle factors 
that trigger SCD crisis; community networks and advo-
cacy activities to support the health and well- being of 
patients; and broader social policies and socioeconomic 
and cultural factors.21 22 The simplicity of this figure can 
increase its utility in teaching and training practices, to 
promote the adoption of holistic policies and interven-
tions that are not just medical in nature.
To illuminate the roles of factors depicted in the 
SICKLE model on the health of persons with SCDs, we 
have provided a pen portrait (see online supplementary 
file), structured by sections to map unto various factors 
highlighted in the SICKLE model (individual factors, 
lifestyle factors, social and community factors)
Next, we use the context of Nigeria to illustrate the 
application of the SDH approach to SCDs.
APPLICATION TO PRACTICE
Nigeria has one of the largest populations of people with 
SCDs but also has extreme economic inequalities. The 
lack of SCD- related policies and the adoption of a biomed-
ical approach to SCDs, mean the institutions of society 
(including family, universities and churches) directively 
expect those with the sickle cell trait (those who carry 
a gene) to understand their status and its implications. 
In such contexts, a couple that both have sickle cell trait 
(with a one in four chance of having a child with sickle 
cell disease in each pregnancy) are counselled to avoid 
marriage and sexual relations. The high fatality rate of 
sickle cell disease (ie, Hb SS disease) in sub- Saharan 
Africa, often intersects with deprivation and political and 
economic instability to create fatalistic assumptions that 
children cannot live beyond 5 years old or will not reach 
the age of 18.
Such values and norms can increase stigmatisation 
linked to carrier status and giving birth to a child with 
SCD. Expecting individuals to take responsibility for 
SCDs also makes assumptions about agency and family 
life by implying that all women have choice and say over 
their reproductive futures, further shaming those who 
do not take control of reproduction in ways that match 
societal expectation(s). Moreover, divestment of public 
health policies also unethically and inadvertently fosters 
stigma, sexism and (dis)ableism affecting people with 
SCDs and those with carrier status. In such contexts, we 
argue instead that policy and interventions development 
for SCDs could be conceptualised with ensuring equity 
and reducing inequalities as their main aim as shown in 
table 1. This conceptualisation will benefit both people 
with SCD and the general population too.
Table 1 depicts how interventions can manifest 
depending on the perspectives (biomedical approaches 
vs SDH) and policies that underlie their development.
CONCLUSION
The comparison of key features of interventions in the 
table suggests that a purely biomedical/biopsychosocial 
framing of SCD as burden sets in motion a series of public 
health policies that inadvertently ignore a duty of care 
and right to health. A biomedical approach also fosters 
unethical practices that are inconsistent with contempo-
rary understandings about SCD being clinically, as much 
as socially and environmentally determined. The ongoing 
COVID-19 pandemic shows the importance of thinking 
about health inequalities in broader social justice terms, 
to understand why some people are more affected but also 
to ensure provision of high- quality care and mutual aid 
to people with disabilities and SCD. The postpandemic 
situation cannot mean political business as usual as the 
improved survival and quality of life of millions of people 
with SCD in sub- Saharan Africa depends on holistic 
Figure 1 Social determinants of sickle cell disorders: 
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policies and strategies that are underpinned by an SDH 
approach to SCD, rather than on screening programmes 
or clinical treatments and cures alone. While the inter-
ventions listed in table 1 are not meant to be exhaustive, 
applying an SDH lens to implement them will accelerate 
the achievement of several UN SDGs. Notable for people 
with SCD are as follows: goal 1 of ending poverty, goal 
2 of ending hunger and improving nutrition, goal 3 of 
ensuring healthy lives and improving well- being, goal 4 of 
ensuring inclusive education and lifelong learning, goal 
5 of achieving gender equality and goal 8 of promoting 
full and productive employment for all.
Twitter Maria Berghs @MariaBerghs and Bassey Ebenso @B_Ebenso
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Table 1 Showing features of key interventions by the perspectives that underpin their design
Interventions Biomedical and biopsychosocial approaches Social determinants of health
Estimating prevalence Magnitude of SCDs is seen as a burden, that 
potentially stigmatises people with SCDs and carrier 
status.
Prevalence is seen as part of holistic policies 
that combine life- course approach and 
universal access to healthcare for people with 
SCDs and general population.
Screening services Identify children with SCDs to ensure care. This can 
cause stigmatisation of women carrying children 
with SCDs and people with SCDs.
Screen to ensure timely treatment to save 
lives of those born with SCDs and also ensure 
family planning, reproductive choices and 
maternal health policy exists in society.
Medical care SCDs often seen as a specialised issue in health 
services with need for particular training. Under- 
invested and neglected. Payment expected for 
treatment. Research focuses on development of 
cures and new therapies neglected for years.
SCD is considered specialised but it 
incorporates duty of care and is linked to other 
parts of healthcare and investments made 
in therapies. Universal health coverage is 
implemented alongside investments in cures. 
Recognition of pluralistic health belief systems 
and importance of patient support groups.
Mental health Identify mental health issues such as depression 
and stress as triggers for SCD crisis. The condition 
is viewed as stigmatised.
Health and social care focus on strengthening 
friendships, relationships and community 
connections that support persons with SCDs 
to cope better and understand psychological 
stressors.
Lifestyle Care and nutrition viewed as family and individual 
management usually targeted to mothers as part of 
early intervention programmes.
Care and nutrition as part of a country’s 
policies for general population taught in 
schools, universities and public communication 
programmes. The contribution of the extended 
family and community in care of those with 
SCDs is recognised.
School Information about SCDs is seen as biomedical 
education with no policies in schools for inclusion.
SCDs integrated in all aspects of education 
and inclusive disability policies in schools and 
higher education institutions.
Employment People with SCDs are unable to work due to 
invisible disabilities or require special provisions to 
work.
Work is made accessible for those with 
invisible disabilities with reasonable 
adjustments, welfare (or a basic universal 
income) and pension plans for people with 
chronic conditions exist in society.
Housing and sanitation Housing and sanitation excluded from these 
approaches.
Housing and sanitation should be safe and 
accessible. Hygiene taught in schools.
Environment Environmental conditions viewed as ‘trigger’ for 
disease, warnings about extremes in temperature 
but no policies to support improvements in 
environmental conditions.
Environmental policies focused on housing 
conditions, access to heating and/or air 
conditioning to support a stable body 
temperature. Climate change and reduction 
of pollution. Disability and chronic conditions 
included in pandemic preparedness and 
planning throughout.
SCD, sickle cell disorders.
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